rdf:type |
|
lifeskim:mentions |
umls-concept:C0006610,
umls-concept:C0013216,
umls-concept:C0085862,
umls-concept:C0205263,
umls-concept:C0221908,
umls-concept:C0392747,
umls-concept:C0441889,
umls-concept:C0443172,
umls-concept:C0919267,
umls-concept:C1274040,
umls-concept:C1299583,
umls-concept:C1511572,
umls-concept:C1549571,
umls-concept:C1608386,
umls-concept:C2698872
|
pubmed:issue |
5
|
pubmed:dateCreated |
2007-5-9
|
pubmed:abstractText |
CA 125 assays enable treatment response monitoring in ovarian cancer.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0923-7534
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
881-5
|
pubmed:dateRevised |
2007-11-20
|
pubmed:meshHeading |
pubmed-meshheading:17301071-Adult,
pubmed-meshheading:17301071-Aged,
pubmed-meshheading:17301071-Aged, 80 and over,
pubmed-meshheading:17301071-CA-125 Antigen,
pubmed-meshheading:17301071-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:17301071-Female,
pubmed-meshheading:17301071-Follow-Up Studies,
pubmed-meshheading:17301071-Humans,
pubmed-meshheading:17301071-Middle Aged,
pubmed-meshheading:17301071-Neoplasm Staging,
pubmed-meshheading:17301071-Neoplasms, Glandular and Epithelial,
pubmed-meshheading:17301071-Ovarian Neoplasms,
pubmed-meshheading:17301071-Prognosis,
pubmed-meshheading:17301071-Second-Look Surgery,
pubmed-meshheading:17301071-Survival Analysis,
pubmed-meshheading:17301071-Time Factors,
pubmed-meshheading:17301071-Treatment Outcome
|
pubmed:year |
2007
|
pubmed:articleTitle |
Change in CA 125 levels after the first cycle of induction chemotherapy is an independent predictor of epithelial ovarian tumour outcome.
|
pubmed:affiliation |
Laboratoire de Biologie Médicale, Centre Georges François Leclerc, Dijon, France. jriedinger@dijon.fnclcc.fr
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study
|